ES2185621T3 - Proteasa y compuestos adn relacionados. - Google Patents
Proteasa y compuestos adn relacionados.Info
- Publication number
- ES2185621T3 ES2185621T3 ES93304103T ES93304103T ES2185621T3 ES 2185621 T3 ES2185621 T3 ES 2185621T3 ES 93304103 T ES93304103 T ES 93304103T ES 93304103 T ES93304103 T ES 93304103T ES 2185621 T3 ES2185621 T3 ES 2185621T3
- Authority
- ES
- Spain
- Prior art keywords
- protease
- related dna
- dna compounds
- compounds
- provides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Abstract
LA INVENCION SE REFIERE A UNA PROTEINA EXFOLIADORA DE PROTEINAS PRECURSORA DE AMILOIDES Y A COMPUESTOS DE ACIDO NUCLEICO RELACIONADOS. LA INVENCION TAMBIEN SE REFIERE A METODOS, MATERIALES Y ENSAYOS. LOS COMPUESTOS DE ESTA INVENCION FAVORECERAN LA CARACTERIZACION DE ENFERMEDADES NEUROLOGICAS TALES COMO LA ENFERMEDAD DE ALZHEIMER Y EL SINDROME DE DOWN.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89154292A | 1992-05-28 | 1992-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2185621T3 true ES2185621T3 (es) | 2003-05-01 |
Family
ID=25398377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93304103T Expired - Lifetime ES2185621T3 (es) | 1992-05-28 | 1993-05-26 | Proteasa y compuestos adn relacionados. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5733768A (es) |
EP (1) | EP0576152B1 (es) |
JP (1) | JP3568552B2 (es) |
KR (1) | KR930023465A (es) |
AT (1) | ATE227343T1 (es) |
AU (1) | AU670080B2 (es) |
BR (1) | BR9302075A (es) |
CA (1) | CA2096911C (es) |
CZ (1) | CZ98293A3 (es) |
DE (1) | DE69332462T2 (es) |
ES (1) | ES2185621T3 (es) |
FI (1) | FI932425A (es) |
HU (1) | HUT69612A (es) |
IL (1) | IL105793A0 (es) |
MX (1) | MX9303082A (es) |
NO (1) | NO931889L (es) |
PL (1) | PL299053A1 (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6531586B1 (en) | 1995-04-28 | 2003-03-11 | The Hospital For Sick Children | Genetic sequences related to Alzheimer's Disease |
US5986054A (en) * | 1995-04-28 | 1999-11-16 | The Hospital For Sick Children, Hsc Research And Development Limited Partnership | Genetic sequences and proteins related to alzheimer's disease |
US6210919B1 (en) | 1995-04-28 | 2001-04-03 | Hsc Research And Development Limited Partnership | Genetic sequences and proteins related to alzheimer's disease |
EP0871720A2 (en) * | 1995-06-07 | 1998-10-21 | Athena Neurosciences, Inc. | Beta-secretase, antibodies to beta-secretase, and assays for detecting beta-secretase inhibition |
US5744346A (en) * | 1995-06-07 | 1998-04-28 | Athena Neurosciences, Inc. | β-secretase |
US6329163B1 (en) | 1995-06-07 | 2001-12-11 | Elan Pharmaceuticals, Inc. | Assays for detecting β-secretase inhibition |
JP2000506375A (ja) * | 1996-01-26 | 2000-05-30 | エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ | アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用 |
AU4480797A (en) * | 1996-09-13 | 1998-04-02 | Dana-Farber Cancer Institute | Protease m, a novel serine protease |
WO1999064587A1 (fr) * | 1998-06-05 | 1999-12-16 | Aventis Pharma S.A. | Polypeptides possedant une activite de type beta-secretase |
FR2779444A1 (fr) * | 1998-06-05 | 1999-12-10 | Rhone Poulenc Rorer Sa | Polypeptides possedant une activite de type beta-secretase et capables de cliver le precurseur naturel du peptide beta-amyloide (app) |
ES2273496T3 (es) * | 1998-07-02 | 2007-05-01 | Fuso Pharmaceutical Industries, Ltd. | Anticuerpos monoclonales que se unen especificamente a una serina proteasa y utilizacion de los mismos. |
US6844148B1 (en) * | 1998-09-24 | 2005-01-18 | Pharmacia & Upjohn Company | Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
SG113454A1 (en) | 1998-09-24 | 2005-08-29 | Upjohn Co | Alzheimer's disease secretase |
US20040234976A1 (en) * | 1998-09-24 | 2004-11-25 | Gurney Mark E. | Alzheimer's disease secretase, app substrates therefor, and uses therefor |
US6699671B1 (en) | 1998-09-24 | 2004-03-02 | Pharmacia & Upjohn Company | Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
US6245884B1 (en) | 1998-10-16 | 2001-06-12 | Vivian Y. H. Hook | Secretases related to alzheimer's dementia |
US6313268B1 (en) | 1998-10-16 | 2001-11-06 | Vivian Y. H. Hook | Secretases related to Alzheimer's dementia |
US7456007B1 (en) | 1998-12-31 | 2008-11-25 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
US7115410B1 (en) * | 1999-02-10 | 2006-10-03 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
JP4653318B2 (ja) | 1999-02-10 | 2011-03-16 | エラン ファーマシューティカルズ,インコーポレイテッド | βセクレターゼ酵素組成物および方法 |
US6545127B1 (en) | 1999-06-28 | 2003-04-08 | Oklahoma Medical Research Foundation | Catalytically active recombinant memapsin and methods of use thereof |
US20020049303A1 (en) * | 1999-06-28 | 2002-04-25 | Tang Jordan J. N. | Catalytically active recombinant memapsin and methods of use thereof |
US20090162883A1 (en) * | 1999-09-23 | 2009-06-25 | Pharmacia & Upjohn Company | Alzheimer's Disease Secretase, APP Substrates Thereof, and Uses Thereof |
US7514408B1 (en) | 1999-12-02 | 2009-04-07 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
US6962793B2 (en) | 2000-10-27 | 2005-11-08 | Mount Sinai Hospital | Methods for detecting Alzheimers disease |
US20040096915A1 (en) * | 2000-10-27 | 2004-05-20 | Diamandis Eleftherios P. | Methods for detecting ovarian cancer |
US20040121947A1 (en) * | 2000-12-28 | 2004-06-24 | Oklahoma Medical Research Foundation | Compounds which inhibit beta-secretase activity and methods of use thereof |
US20060234944A1 (en) * | 2001-10-23 | 2006-10-19 | Oklahoma Medical Reseach Foundation | Beta-secretase inhibitors and methods of use |
EP1448218A4 (en) * | 2001-10-23 | 2009-01-14 | Oklahoma Med Res Found | BETA SECRETASE INHIBITORS AND METHODS OF USE |
CA2468651A1 (en) * | 2003-06-13 | 2004-12-13 | Eleftherios P. Diamandis | Detection of neurodegenerative diseases |
US20070092517A1 (en) * | 2005-08-10 | 2007-04-26 | Oklahoma Medical Research Foundation | Truncated memapsin 2 compositions and treatments |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991013904A1 (en) * | 1990-03-05 | 1991-09-19 | Cephalon, Inc. | Chymotrypsin-like proteases and their inhibitors |
US5252463A (en) * | 1990-06-22 | 1993-10-12 | The Du Pont Merck Pharmaceutical Company | Clipsin, a chymotrypsin-like protease and method of using same |
WO1992003542A1 (en) * | 1990-08-17 | 1992-03-05 | Boston University | PROTEASES CAUSING ABNORMAL DEGRADATION OF AMYLOID β-PROTEIN PRECURSOR |
US5292652A (en) * | 1990-10-05 | 1994-03-08 | Athena Neurosciences, Inc. | Amyloidin protease and uses thereof |
-
1993
- 1993-05-24 IL IL105793A patent/IL105793A0/xx unknown
- 1993-05-25 CA CA002096911A patent/CA2096911C/en not_active Expired - Lifetime
- 1993-05-25 NO NO931889A patent/NO931889L/no unknown
- 1993-05-25 PL PL29905393A patent/PL299053A1/xx unknown
- 1993-05-26 DE DE69332462T patent/DE69332462T2/de not_active Expired - Lifetime
- 1993-05-26 BR BR9302075A patent/BR9302075A/pt not_active Application Discontinuation
- 1993-05-26 ES ES93304103T patent/ES2185621T3/es not_active Expired - Lifetime
- 1993-05-26 AT AT93304103T patent/ATE227343T1/de not_active IP Right Cessation
- 1993-05-26 MX MX9303082A patent/MX9303082A/es unknown
- 1993-05-26 EP EP93304103A patent/EP0576152B1/en not_active Expired - Lifetime
- 1993-05-27 AU AU39864/93A patent/AU670080B2/en not_active Ceased
- 1993-05-27 JP JP12576093A patent/JP3568552B2/ja not_active Expired - Lifetime
- 1993-05-27 KR KR1019930009456A patent/KR930023465A/ko not_active Application Discontinuation
- 1993-05-27 HU HU9301557A patent/HUT69612A/hu unknown
- 1993-05-27 FI FI932425A patent/FI932425A/fi not_active Application Discontinuation
- 1993-06-23 CZ CZ93982A patent/CZ98293A3/cs unknown
-
1994
- 1994-12-22 US US08/361,395 patent/US5733768A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0576152A1 (en) | 1993-12-29 |
MX9303082A (es) | 1994-06-30 |
HUT69612A (en) | 1995-09-28 |
US5733768A (en) | 1998-03-31 |
CA2096911A1 (en) | 1993-11-29 |
FI932425A0 (fi) | 1993-05-27 |
FI932425A (fi) | 1993-11-29 |
NO931889D0 (no) | 1993-05-25 |
DE69332462T2 (de) | 2003-07-10 |
PL299053A1 (en) | 1994-02-21 |
JP3568552B2 (ja) | 2004-09-22 |
CA2096911C (en) | 2004-11-02 |
EP0576152B1 (en) | 2002-11-06 |
IL105793A0 (en) | 1993-09-22 |
NO931889L (no) | 1993-11-29 |
AU3986493A (en) | 1993-12-02 |
HU9301557D0 (en) | 1993-10-28 |
JPH0662855A (ja) | 1994-03-08 |
ATE227343T1 (de) | 2002-11-15 |
BR9302075A (pt) | 1993-11-30 |
DE69332462D1 (de) | 2002-12-12 |
KR930023465A (ko) | 1993-12-18 |
CZ98293A3 (en) | 1994-02-16 |
AU670080B2 (en) | 1996-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2185621T3 (es) | Proteasa y compuestos adn relacionados. | |
FI885504A (fi) | Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning. | |
DE69841653D1 (de) | Katalytische monoklonale antikörper mit proteaseaktivität zur selektiven lysis der proteinkomponente von mit pathologischen konditionen zusammenhängenden plaques und aggregaten | |
ATE549347T1 (de) | Gene von säugetiere, und damit verbundene reagentien, methoden | |
DE69435038D1 (de) | Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie | |
PT733069E (pt) | Antigenios ctla-8 de primata purificados e reagentes relacionados | |
FI870113A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5,6-substioitujenN-(substituoitu-fenyyli)-2-pyrimidiiniamiinien valmistamiseksi | |
CY1111950T1 (el) | 32 ανθρωπινες εκκρινομενες πρωτεϊνες | |
ATE394484T1 (de) | Smad 6 und dessen anwendungen | |
DE69836630D1 (de) | Menschliche toll-ähnliche rezeptorproteine, zugehörige reagenzien und verfahren | |
WO1999053061A3 (en) | Tumor associated nucleic acids and uses therefor | |
IS4408A (is) | Telomerasi úr spendýrum | |
PT584446E (pt) | Proteina de transferencia de trigliceridos microssomicos | |
DE69728897D1 (de) | Saeugetierchemokine | |
DE69328060T2 (de) | Angiotensin-II Typ-1 Rezeptor und dessen Herstellung | |
DE3852625T2 (de) | Vektoren und Verbindungen zur Expression von Zymogen-Formen von menschlichem Protein C. | |
DK1129191T3 (da) | Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme | |
EP1428833A3 (en) | 207 human secreted proteins | |
ATE103635T1 (de) | Reg-gen und dadurch kodiertes protein. | |
MX9709834A (es) | Metodo de transesterificacion para preparar poliol poliesteres. | |
SE9300686D0 (sv) | Novel polypeptides |